Fulcrum Therapeutics, Inc. Soared

Tue 19 Nov 19 at 05:30 PM
Fulcrum Therapeutics, Inc. Soared

Fulcrum Therapeutics, Inc. (FULC:NASDAQ) shot up today at $10.09, representing a gain of 25%. On Mon, 18 Nov 19, FULC:NASDAQ touched a New 2-Week High of $8.07. The stock appeared on our News Catalysts scanner on Thu, 14 Nov 19 at 08:21 AM. From Tue, 29 Oct 19, the stock recorded 57.14% Up Days and 46.67% Green Days

The share price of the company has been moving sideways in recent weeks.

About Fulcrum Therapeutics, Inc. (FULC:NASDAQ)

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. It has developed a proprietary product engine which employs to identify and validate cellular drug targets that can modulate gene expression. Its product candidate, losmapimod, is a small molecule that was developed for the treatment of FSHD, a muscle wasting disorder that leads to physical impairments and disability.

Share